WO2008060833A3 - Composition, method, system, and kit for optical electrophysiology - Google Patents

Composition, method, system, and kit for optical electrophysiology Download PDF

Info

Publication number
WO2008060833A3
WO2008060833A3 PCT/US2007/082386 US2007082386W WO2008060833A3 WO 2008060833 A3 WO2008060833 A3 WO 2008060833A3 US 2007082386 W US2007082386 W US 2007082386W WO 2008060833 A3 WO2008060833 A3 WO 2008060833A3
Authority
WO
WIPO (PCT)
Prior art keywords
tissue
kit
composition
thick portion
treated
Prior art date
Application number
PCT/US2007/082386
Other languages
French (fr)
Other versions
WO2008060833A2 (en
Inventor
Arkady M Pertsov
Arvydas Matiukas
Leslie M Loew
Joseph P Wuskell
Original Assignee
Univ New York State Res Found
Univ Connecticut
Arkady M Pertsov
Arvydas Matiukas
Leslie M Loew
Joseph P Wuskell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found, Univ Connecticut, Arkady M Pertsov, Arvydas Matiukas, Leslie M Loew, Joseph P Wuskell filed Critical Univ New York State Res Found
Publication of WO2008060833A2 publication Critical patent/WO2008060833A2/en
Publication of WO2008060833A3 publication Critical patent/WO2008060833A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/0075—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain being part of an heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/10—The polymethine chain containing an even number of >CH- groups
    • C09B23/107—The polymethine chain containing an even number of >CH- groups four >CH- groups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47—Scattering, i.e. diffuse reflection
    • G01N21/4795—Scattering, i.e. diffuse reflection spatially resolved investigating of object in scattering medium
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2503/00—Evaluating a particular growth phase or type of persons or animals
    • A61B2503/40—Animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Optics & Photonics (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

The present invention provides a method of optical electrophysiological probing, including: providing a fluorescing chemical probe; contacting a thick portion of tissue with the fluorescing chemical probe to create a thick portion of treated tissue; applying a first range of wavelengths of electromagnetic radiation to the treated portion of tissue; and detecting a plurality of depth-specific emission wavelengths emitted from the thick portion of treated tissue.
PCT/US2007/082386 2006-10-24 2007-10-24 Composition, method, system, and kit for optical electrophysiology WO2008060833A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85441806P 2006-10-24 2006-10-24
US60/854,418 2006-10-24

Publications (2)

Publication Number Publication Date
WO2008060833A2 WO2008060833A2 (en) 2008-05-22
WO2008060833A3 true WO2008060833A3 (en) 2008-11-20

Family

ID=39402369

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/082386 WO2008060833A2 (en) 2006-10-24 2007-10-24 Composition, method, system, and kit for optical electrophysiology

Country Status (2)

Country Link
US (3) US8155730B2 (en)
WO (1) WO2008060833A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008040804B4 (en) * 2008-07-28 2021-07-29 Carl Zeiss Meditec Ag Method, surgical microscope and analysis system for the quantitative representation of blood flow
JP2013122443A (en) * 2011-11-11 2013-06-20 Hideo Ando Biological activity measuring method, biological activity measuring device, method for transfer of biological activity detection signal and method for provision of service using biological activity information
WO2015095344A1 (en) * 2013-12-17 2015-06-25 University Of Chicago Voltage sensitive composition and method of use thereof
US10299692B2 (en) 2015-05-13 2019-05-28 Ep Solutions, S.A. Systems, components, devices and methods for cardiac mapping using numerical reconstruction of cardiac action potentials
CA3028084A1 (en) * 2015-07-06 2017-01-12 Scinovia Corp. Fluorescence based flow imaging and measurements
EP3589639A4 (en) 2017-03-02 2021-03-17 Akita Innovations LLC Voltage sensitive dyes

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5865738A (en) * 1993-12-10 1999-02-02 Regents Of The University Of California Tissue viability monitor

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627027A (en) 1986-04-18 1997-05-06 Carnegie Mellon University Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods
EP0449883B1 (en) * 1988-12-21 1996-01-31 Massachusetts Institute Of Technology A method for laser induced fluorescence of tissue
US5046501A (en) * 1989-01-18 1991-09-10 Wayne State University Atherosclerotic identification
GB9015793D0 (en) * 1990-07-18 1990-09-05 Medical Res Council Confocal scanning optical microscope
US5845639A (en) * 1990-08-10 1998-12-08 Board Of Regents Of The University Of Washington Optical imaging methods
US5127730A (en) * 1990-08-10 1992-07-07 Regents Of The University Of Minnesota Multi-color laser scanning confocal imaging system
US6671540B1 (en) 1990-08-10 2003-12-30 Daryl W. Hochman Methods and systems for detecting abnormal tissue using spectroscopic techniques
ATE145805T1 (en) 1991-03-25 1996-12-15 Hoeft Andreas DEVICE AND METHOD FOR DETERMINING THE CARDIAC OUTPUT
US5208651A (en) * 1991-07-16 1993-05-04 The Regents Of The University Of California Apparatus and method for measuring fluorescence intensities at a plurality of wavelengths and lifetimes
US5698397A (en) * 1995-06-07 1997-12-16 Sri International Up-converting reporters for biological and other assays using laser excitation techniques
EP0627643B1 (en) * 1993-06-03 1999-05-06 Hamamatsu Photonics K.K. Laser scanning optical system using axicon
DE4445065A1 (en) 1994-12-07 1996-06-13 Diagnostikforschung Inst Methods for in-vivo diagnostics using NIR radiation
US5697373A (en) * 1995-03-14 1997-12-16 Board Of Regents, The University Of Texas System Optical method and apparatus for the diagnosis of cervical precancers using raman and fluorescence spectroscopies
US5631141A (en) 1995-05-05 1997-05-20 The Regents Of The University Of California High resolution biosensor for in-situ microthermometry
US5616502A (en) 1995-05-19 1997-04-01 Molecular Probes, Inc. Non-specific protein staining using merocyanine dyes
US6342379B1 (en) 1995-06-07 2002-01-29 The Regents Of The University Of California Detection of transmembrane potentials by optical methods
US5865754A (en) * 1995-08-24 1999-02-02 Purdue Research Foundation Office Of Technology Transfer Fluorescence imaging system and method
US5862273A (en) * 1996-02-23 1999-01-19 Kaiser Optical Systems, Inc. Fiber optic probe with integral optical filtering
US5842995A (en) * 1996-06-28 1998-12-01 Board Of Regents, The Univerisity Of Texas System Spectroscopic probe for in vivo measurement of raman signals
DE19635038A1 (en) 1996-08-29 1998-03-12 Pulsion Verwaltungs Gmbh & Co Method for the non-invasive determination of cerebral blood flow by means of near infrared spectroscopy
EP0893965B1 (en) 1997-01-08 2005-03-09 Biosense Webster, Inc. Monitoring of myocardial revascularization
US6201989B1 (en) * 1997-03-13 2001-03-13 Biomax Technologies Inc. Methods and apparatus for detecting the rejection of transplanted tissue
US6297018B1 (en) * 1998-04-17 2001-10-02 Ljl Biosystems, Inc. Methods and apparatus for detecting nucleic acid polymorphisms
US5955737A (en) * 1997-10-27 1999-09-21 Systems & Processes Engineering Corporation Chemometric analysis for extraction of individual fluorescence spectrum and lifetimes from a target mixture
US6151522A (en) * 1998-03-16 2000-11-21 The Research Foundation Of Cuny Method and system for examining biological materials using low power CW excitation raman spectroscopy
IL125614A (en) 1998-07-31 2003-01-12 Amiram Grinvald System and method for non-invasive imaging of retinal function
US6272376B1 (en) * 1999-01-22 2001-08-07 Cedars-Sinai Medical Center Time-resolved, laser-induced fluorescence for the characterization of organic material
US6339714B1 (en) 1999-09-13 2002-01-15 Bo Chen Apparatus and method for measuring concentrations of a dye in a living organism
CN1409818A (en) * 1999-11-19 2003-04-09 乔宾伊冯公司 Compact spectrofluorometer
US7597878B2 (en) 2000-09-19 2009-10-06 Li-Cor, Inc. Optical fluorescent imaging
US6663847B1 (en) 2000-10-13 2003-12-16 Mallinckrodt Inc. Dynamic organ function monitoring agents
AU2002236683A1 (en) 2000-10-27 2002-05-21 Beth Israel Deaconess Medical Center Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates
WO2002038806A2 (en) * 2000-11-13 2002-05-16 Gnothis Holding Sa Detection of nucleic acid polymorphisms
US7139598B2 (en) * 2002-04-04 2006-11-21 Veralight, Inc. Determination of a measure of a glycation end-product or disease state using tissue fluorescence
US20020158211A1 (en) * 2001-04-16 2002-10-31 Dakota Technologies, Inc. Multi-dimensional fluorescence apparatus and method for rapid and highly sensitive quantitative analysis of mixtures
DE10120980B4 (en) 2001-05-01 2009-12-03 Pulsion Medical Systems Ag A method, apparatus and computer program for determining blood flow in a tissue or organ region
US6757554B2 (en) 2001-05-22 2004-06-29 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California Measurement of cardiac output and blood volume by non-invasive detection of indicator dilution
EP1401479B1 (en) * 2001-06-04 2007-04-18 The General Hospital Corporation Detection and therapy of vulnerable plaque with photodynamic compounds
DE10137530A1 (en) * 2001-08-01 2003-02-13 Presens Prec Sensing Gmbh Arrangement and method for multiple fluorescence measurement
US7272252B2 (en) * 2002-06-12 2007-09-18 Clarient, Inc. Automated system for combining bright field and fluorescent microscopy
US7754884B2 (en) 2005-01-03 2010-07-13 Vanderbilt University Targeted, NIR imaging agents for therapy efficacy monitoring, deep tissue disease demarcation and deep tissue imaging
US7190993B2 (en) 2003-11-04 2007-03-13 Medtronic, Inc. Implantable medical device having optical fiber for sensing electrical activity
DE10358735B4 (en) * 2003-12-15 2011-04-21 Siemens Ag Catheter device comprising a catheter, in particular an intravascular catheter
WO2006058187A2 (en) * 2004-11-23 2006-06-01 Robert Eric Betzig Optical lattice microscopy
WO2006102167A2 (en) 2005-03-18 2006-09-28 Stanford University Compounds for tissue imaging and methods of use thereof
US8227621B2 (en) 2005-06-30 2012-07-24 Li-Cor, Inc. Cyanine dyes and methods of use
EP1760467A1 (en) 2005-09-02 2007-03-07 Schering AG Optically fluorescent nanoparticles
US20070135803A1 (en) 2005-09-14 2007-06-14 Amir Belson Methods and apparatus for performing transluminal and other procedures
WO2007047690A1 (en) * 2005-10-14 2007-04-26 The General Hospital Corporation Spectral- and frequency- encoded fluorescence imaging
US20070223006A1 (en) * 2006-01-19 2007-09-27 The General Hospital Corporation Systems and methods for performing rapid fluorescence lifetime, excitation and emission spectral measurements
US20080038686A1 (en) * 2006-04-18 2008-02-14 Shigemi Nagai Methods and kits for early stage caries detection
US8554035B2 (en) * 2006-10-26 2013-10-08 Cornell Research Foundation, Inc. Production of optical pulses at a desired wavelength using soliton self-frequency shift in higher-order-mode fiber

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5865738A (en) * 1993-12-10 1999-02-02 Regents Of The University Of California Tissue viability monitor

Also Published As

Publication number Publication date
US9636424B2 (en) 2017-05-02
US8155730B2 (en) 2012-04-10
US20160256576A1 (en) 2016-09-08
US9357924B2 (en) 2016-06-07
WO2008060833A2 (en) 2008-05-22
US20120196893A1 (en) 2012-08-02
US20080097222A1 (en) 2008-04-24

Similar Documents

Publication Publication Date Title
WO2008060833A3 (en) Composition, method, system, and kit for optical electrophysiology
ES2530843T3 (en) MicroRNA based methods for the diagnosis of pancreatic cancer
EP3501384A3 (en) Method for fluorescence-based imaging and monitoring
WO2012021015A3 (en) Method for simultaneously detecting fluorescence and raman signals for multiple fluorescence and raman signal targets, and medical imaging device for simultaneously detecting multiple targets using the method
WO2007002323A3 (en) System and method for monitoring of end organ oxygenation by measurement of in vivo cellular energy status
WO2010120942A3 (en) Histone modification patterns for clinical diagnosis and prognosis of cancer
WO2010083204A3 (en) Noninvasive measurement of flavonoid compounds in biological tissue
WO2006119431A3 (en) Electromagnetic characterization of tissue
WO2013009655A3 (en) Uses of labeled hsp90 inhibitors
WO2007087315A3 (en) Method and system for combined raman and libs detection
BRPI0915240A2 (en) method for treating cancer, method for evaluating a patient undergoing cancer treatment, method for evaluating a patient who has or suspected cancer and using an anti-c-met antibody
NZ596163A (en) Diagnostic devices and related methods
AR057323A1 (en) METHOD FOR PREDICTION OF THE RESPONSE TO A TREATMENT
CL2008002089A1 (en) Compound for regeneration of tissues comprising at least one substance derived from blood and hyaluronic acid and / or at least one compound derived from hyaluronic acid; method for the preparation of said compound.
WO2010031056A3 (en) Methods and compositions for modulating ire1, src, and abl activity
WO2010015607A3 (en) Method of evaluating oral cancer risk in human
BR112012014925A2 (en) beta cell replication promoting compounds and methods of using them
BRPI0912927A2 (en) "Method of detecting a vegf independent tumor in an individual and method of treating a vegf independent tumor in an individual"
HK1133295A1 (en) Use of protein s100a12 as a marker for colorectal cancer s100a12
WO2013140350A3 (en) Method and apparatus for characterising samples by measuring light scattering and fluorescence
WO2008034968A3 (en) Method for the quantitative measurement of biomolecular targets deposited on a biochip, and device for implementing it
WO2008117027A3 (en) Altered mitochondrial activity in diseases resulting from oxidative stress
WO2006066917A3 (en) Use of asc as a marker for colorectal cancer
WO2011008814A3 (en) Multiplexed measurement of exogenous and endogenous dna
FR2897940B1 (en) METHOD FOR COLORING TISSUE BY FLUORESCENCE

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07868564

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07868564

Country of ref document: EP

Kind code of ref document: A2